Forte Biosciences, Inc. 8-K Summary
Business Context and Reporting Period
This Current Report on Form 8-K was filed by Forte Biosciences, Inc. (FBRX) on January 12, 2023, covering events occurring on January 6, 2023, and January 10, 2023. The filing addresses changes to the composition of the Board of Directors.
Key Financial Metrics
The filing text does not provide revenue, profit, cash flow, margin, debt, or liquidity metrics. This report focuses exclusively on corporate governance changes.
Material Changes
- Resignation of Director: Patricia Walker, M.D., Ph.D., resigned from the Board of Directors and all committees effective January 6, 2023. The resignation was not due to any disagreement with the Company regarding operations, policies, or practices.
- Appointment of Director: David Gryska, M.B.A., was appointed to the Board effective January 10, 2023, to fill the vacancy created by Dr. Walker's resignation. He was appointed as a Class II director with a term expiring in 2025 and was named a member of the Audit Committee.
Compensation and Governance Details
Mr. Gryska's compensation includes:
- Cash Retainer: $40,000 per year for Board service and $8,000 per year for Audit Committee service, paid quarterly in arrears on a pro-rata basis.
- Equity Grant: A stock option for 50,000 shares of Common Stock, vesting in equal monthly installments over three years, contingent on continued service.
Mr. Gryska brings over 35 years of experience as a senior financial executive in the life sciences sector, including prior CFO roles at Incyte Corporation, Celgene Corporation, and Scios, Inc.
Investor Verification Checklist
- Verify the effective dates of Dr. Walker's resignation and Mr. Gryska's appointment.
- Confirm the vesting schedule and terms of the 50,000-share stock option granted to Mr. Gryska.
- Review the Company's amended and restated non-employee director compensation policy for full details on cash retainers.
- Check subsequent filings for any further changes to the Board composition or committee assignments.